Board summary
Key figures
45,283
Registered population
70.0% aged 18–64
14.2%
Aged 65+
ICB 19.0% · England 17.9%
27.0%
Ethnic minority (non-White)
8.6% Asian · England 9.6%
66.8%
In IMD quintile 1
ICB 31.9% · England 21.0%
~24,978
Core20 residents (est.)
Resident basis; registered basis ~30,295 · see page 3
6,084
Hypertension register
-2.34% in 3 yrs · England +5.60%
816
SMI register
9.7% of Liverpool (LAD)'s
1,677
COPD register
Reviews +14.14% in 3 yrs
Forecast to 2030
6,149
Hypertension patients, 2030
+65 on today
70.6%
QRISK ≥20% on statins, 2030
+0.96pp over 3 yrs
3.4%
Cancer prevalence, 2030
England 4.5%
Three things the board should see
Hypertension register fell while England grew.
Hypertension prevalence changed by -2.3% over 2023 to 2025 (England +5.6%) to 13.3% (England 15.2%, unadjusted gap +253 to +812), testing age versus detection.
SMI physical health check recording declined.
Over 2023 to 2025, SMI alcohol recording changed by -5.2 pp to 72.7% (England +5.4 pp, 81.8%) and BMI by -2.7 pp to 72.3%.
Heart failure and hypertension control exceed England.
Heart failure reviews grew +60.5% over 2023 to 2025 (England +8.7%) to 85.2% (England 78.5%), alongside 72.5% hypertension control (England 70.3%).
Population, age and ethnicity
Working-age adults make up 70.0% of the PCN's 45,283 registered patients
Across six practices, Central Liverpool PCN serves 45,283 registered patients. Working-age adults (18–64) comprise 70.0% (31,699 patients), higher than Liverpool (64.5%), the ICB (61.9%), and England (62.7%). Conversely, 14.2% (6,409 patients) are aged 65+, below Liverpool (15.6%), the ICB (19.0%), and England (17.9%), while 15.8% (7,175 patients) are aged 0–17. In surrounding areas, Census usual residents are 73.0% White (Liverpool 84.0%, ICB 93.0%, England 81.1%) and 27.0% ethnic minorities, though resident ethnicity differs from registered patient lists. Projected population growth to 2030 is 3.5% (Liverpool 3.0%, ICB 2.3%, England 2.3%) under an unverified projection methodology.
Age profile
65+: ICB 19.0%, England 17.9%
Ethnicity
Older people · falls rows are Liverpool (LAD) local-authority (LA) data, not PCN
| Measure | Local | North West | England | Period |
|---|---|---|---|---|
| Falls admissions, 65+, per 100,000 (Liverpool LA) | 3,035 | 2,071 | 1,958 | 2024/25 |
| Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN) | 82.4% | 82.9% | 81.9% | 2024/25 |
| Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN) | 56.2% | 56.6% | 57.4% | 2024/25 |
| Falls admissions, 65 to 79, per 100,000 (Liverpool LA) | 1,652 | 1,021 | 955 | 2024/25 |
| Falls deaths, all ages, per 100,000 (Liverpool LA) | 27.5 | 18.2 | 14.8 | 2022‑24 |
Deprivation and Core20
Core20 cohort comprises 66.8% of Central Liverpool PCN registered patients
Across Central Liverpool PCN, 66.8% of registered patients live in Core20 areas (national IMD quintile 1), exceeding Liverpool (54.9%), NHS Cheshire and Merseyside Integrated Care Board (31.9%), and England (21.0%). Deprivation is concentrated in the top three practices: Vauxhall Health Centre at 93.4% (8,400 estimated patients), Albion Surgery at 92.03% (4,362 estimated patients), and Dingle Park Practice at 86.69% (4,884 estimated patients). This marked concentration highlights where outreach and preventive support are most needed across the network.
% of patients in IMD quintile 1, by practice
Dashed line: England 21.0% · right column: Core20 patients, registered basis
PLUS groups and inclusion health
PLUS groups and inclusion health
816
SMI register
1.79% recorded prevalence
206
Learning disability register
0.45% recorded prevalence
16
Care homes, 690 beds
In the PCN catchment
10.3%
Provide unpaid care
Liverpool (LAD), Census 2021
Central Liverpool PCN records 816 severe mental illness patients (1.8% vs Liverpool 1.4%, ICB 1.1%, England 1.0%; 9.7% of Liverpool's register) and 206 with learning disabilities (0.5% vs 0.6% across Liverpool, ICB, England). Catchment care homes total 16 with 690 beds; Liverpool recorded 35 rough sleepers in autumn 2025. Higher SMI recorded prevalence represents a substantial annual review workload to maintain.
Severe mental illness: physical health checks
SMI physical check recording fell over 2023 to 2025: blood pressure fell 0.2 pp to 76.7% (England +4.4 pp, 83.4%) and BMI fell 2.7 pp to 72.3% (England +5.1 pp, 82.1%). Recall audits may address lags.
Clinical focus: hypertension and lipids
Clinical focus: hypertension and lipids
6,084
Hypertension register
−2.34%
Register growth, 3 yrs
Liverpool (LAD) +2.01% · England +5.60%
+3.78pp
BP control, under 80
≤140/90 · +4.64pp aged 80+
+65
More patients by 2030
Forecast 6,149 (12.73%)
Hypertension case-finding and control
Central Liverpool PCN records 6,084 patients with hypertension, a crude prevalence of 13.3% against 14.0% in Liverpool, 16.8% in the ICB and 15.2% in England. Over 2023 to 2025, the register fell 2.3% (England +5.6%). This leaves an unadjusted benchmark gap of +253 to +812 patients, though having 14.2% aged 65+ (England 17.9%) may contribute. For managed patients, 72.5% are treated to target (England 70.3%) and 88.0% had a recent blood pressure check (England 90.0%). Hypertension prevalence and register growth trail comparators despite strong treatment control, so proactive case finding should be prioritised.
Lipids and statins
Among patients with QRISK ≥ 20%, 68.6% receive lipid-lowering therapy, exceeding Liverpool (65.6%), the ICB (63.2%) and England (63.6%). In CKD, 74.8% receive therapy (England 70.3%). Lipid therapy coverage exceeds benchmarks, so routine annual review processes should be maintained to protect cardiovascular gains.
| Measure | Items | Cost / item | ICB | England | Annual spend |
|---|---|---|---|---|---|
| Lipid-modifying, 2026 | 76,568 | £1.80 | £1.71 | £1.86 | £137,822 |
| Cardiovascular (all), 2025 | 105,577 | £3.99 | £4.37 | £3.33 | £421,252 |
In 2026, the PCN prescribed 76,568 lipid-regulating drug items at £1.80 each (£137,822 spend), compared to £1.82 in Liverpool, £1.71 in the ICB and £1.86 in England. Across these items, the PCN spends £4,594 less than at England's unit cost, but £6,891 more than at the ICB's unit cost. Unit cost differences reflect benchmark spend rather than efficiency or prescribing.
Clinical focus: respiratory, cancer register and children
Clinical focus: respiratory, cancer register and children
Respiratory
+8.65%
Asthma reviews, PCN 3-yr % change
+4.44%
Asthma reviews, England 3-yr % change
−1.81%
Asthma prevalence, PCN 3-yr % change
Asthma prescribing for ages 5-19 reaches 3,692 rate per 1,000, above England (1,488 rate), Liverpool (2,457 rate), and the ICB (2,310 rate). Meanwhile, 62.6% of the 2,784 asthma register had an annual review (England 65.7%), leaving 1,040 patients unreviewed. Second-hand smoking recording for ages 6-19 is 70.5% (201 patients), trailing England (78.8%) and Liverpool (77.4%). In contrast, COPD prevalence is 3.7% (1,677 patients; England 1.9%), with reviews at 76.9% (England 76.4%).
Cancer register and children's immunisation
The cancer register records 1,357 patients (3.0% prevalence; England 3.8%). In Q1 2025/26 COVER data, childhood immunisation trails targets: 6-in-1 at 12 months is 81.2% (England 91.0%), and MMR dose 1 at 24 months is 75.0% (England 88.3%). At age five, MMR dose 2 is 64.8% (15.2 pp below dose 1 at 80.0% and 30.2 pp below the 95.0% target), while 4-in-1 booster reaches 60.0%.
Dashed line: 95% national coverage target · solid tick: England
Early cancer diagnosis
Early cancer diagnosis
55.5%
Cheshire and Merseyside ICB, stage 1–2
55.3%
England, 2022
75%
National ambition by 2028
~2,640
Extra early-stage cases a year to reach the ambition
| Stage 1–2 share by cancer type, 2022 | Cheshire and Merseyside ICB | England | No usable stage | Staged cancers |
|---|---|---|---|---|
| Lung | 40.4% | 33.8% | 11% | 2,354 |
| Breast | 87.1% | 85.4% | 11% | 2,083 |
| Prostate | 52.3% | 53.2% | 12% | 2,037 |
| Bowel | 44.9% | 47.0% | 16% | 1,674 |
| Skin cancer | 86.9% | 87.8% | 21% | 932 |
Across NHS Cheshire and Merseyside ICB in 2022, 55.5% of staged cancers (7,482 of 13,490) were diagnosed at stage 1 or 2, with known stage recorded for 72.8% of cases. This ICB rate is 19.5 pp below the 75.0% ambition by 2028, representing about 2,640 extra early diagnoses across the system, despite a 2.6 pp rise since 2013 (52.8%). Central Liverpool PCN cervical screening coverage is 58.4% (England 66.8%) and breast screening coverage is 63.8% (England 69.9%). At practice level, cervical screening is 45.8% at St. James' Health Centre and 53.6% at Abercromby Family Practice. Lower screening participation across primary care risks later presentation across cancer pathways.
Cancer waits, diagnostics and community services
Cancer waits, diagnostics and community services
Cancer waits and diagnostics, Jul 2026 (provisional)
In July 2026 (provisional), Liverpool Women's NHS Foundation Trust achieved 69.1% on the 62-day cancer standard (Liverpool University Hospitals NHS Foundation Trust 73.3%, Wirral University Teaching Hospital NHS Foundation Trust 77.6%, ICB 76.2%, England 71.2%, standard 85.0%). The trust reached 75.7% on the 28-day faster diagnosis standard (ICB 77.2%, England 79.3%) and 85.4% on the 31-day treatment standard (ICB 95.7%, England 92.5%). Six-week diagnostic waits at the trust were 6.1% for non-obstetric ultrasound and 2.6% for DEXA scans. These provider wait times reflect acute pressures across secondary pathways.
| Pathways within standard (%) | Liverpool Women's | Liverpool | Wirral | Cheshire and Merseyside ICB | England |
|---|---|---|---|---|---|
| 28-day faster diagnosis (75%) | 75.73 | 75.47 | 74.71 | 77.25 | 79.32 |
| 31-day treatment (96%) | 85.42 | 90.51 | 92.53 | 95.71 | 92.50 |
| 62-day referral to treatment (85%) | 69.09 | 73.26 | 77.65 | 76.23 | 71.16 |
| Community services activity | Liverpool residents | Cheshire and Merseyside ICB |
|---|---|---|
| Care contacts | 127,380 | 541,280 |
| Referrals | 15,675 | 97,150 |
| Patients with a contact | 24,970 | 146,240 |
Community services (residents of Liverpool), Jun 2026 (provisional). In June 2026 (provisional), Liverpool residents recorded 127,380 community health service contacts. Adults aged 65 and over accounted for 65.4% of activity (83,300 contacts). While this captures borough-wide resident utilisation rather than an exclusive PCN cohort, it indicates substantial community service involvement with older populations. Joint working with community teams could assist timely referral for older patients.
Practice variation and patient experience
Practice variation and patient experience
GP Patient Survey by practice
| Practice | Responses | % in IMD Q1 | Phone easy | Request led to appt | Overall good |
|---|---|---|---|---|---|
| Albion Surgery | 91 | 92.0 | 75.0% | 59.7% | 88.8% |
| St. James' | 121 | 20.9 | 73.7% | 69.4% | 81.8% |
| Elms | 112 | 73.5 | 68.0% | 69.5% | 81.4% |
| Vauxhall | 74 | 93.4 | 77.1% | 72.3% | 80.7% |
| Abercromby | 95 | 53.3 | 57.0% | 69.6% | 76.0% |
| Dingle Park | 113 | 86.7 | 43.5% | 66.1% | 72.1% |
| England | — | ~21 | 56.9% | 71.6% | 76.7% |
Where the PCN lags
SMI alcohol recording fell 5.2 pp while England rose +5.4 pp
Across 25 monitored measures, Central Liverpool PCN's sharpest three-year lags against England emerged in severe mental illness physical checks and chronic disease registers. Over 2023 to 2025, alcohol recording for patients with psychosis fell 5.2 pp (England +5.4 pp), while dementia prevalence fell 3.5% (England +6.0%), COPD fell 5.5% (England +2.6%), and stroke fell 5.8% (England +2.3%). Conversely, relative strengths include heart failure reviews, which rose +60.5% (England +8.7%) to reach 85.2% (England 78.5%), and breast screening coverage, which rose +19.4% (England +8.4%).
3-year change · PCN vs England
Bars show the direction and scale of relative change. Orange: PCN · Grey: England.
Alcohol record (psychosis)
Dementia register
COPD register
Stroke register
Hypertension register
Heart failure reviews
COPD reviews
Breast screening (53-70)
What the data can't tell us: gaps and local assets
What the data can't tell us: gaps and local assets
| Local assets and voluntary sector | PCN | Liverpool (LAD) | Asset | PCN | Liverpool (LAD) |
|---|---|---|---|---|---|
| Care homes (catchment) | 16 (690 beds) | n/a | Schools (catchment) | 140 | n/a |
| Children's centres | 6 | 26 | Places of worship | 69 | 240 |
| Libraries | 3 | 17 | Homelessness support (VCS) | n/a | 1 |
| Primary schools (LA maintained) | 15 | 91 | Primary academies | 7 | 20 |
| Special schools | n/a | 8 |
0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.
Options for the PCN
Options for the PCN
Each option in full
Option 1
Hypertension case-finding and register audit
Recorded prevalence is 13.3% (6,084 patients) vs 14.0% in Liverpool and 15.2% in England (+253 to +812 unadjusted gap), falling 2.3% over 2023 to 2025 (England +5.6%). For discussion: practices could search for patients with repeated raised blood pressure readings without a diagnosis code and offer opportunistic checks. Low cost, quick to run.
Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.
Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).
Option 2
SMI physical health check recall
Across 816 SMI patients (1.8% vs England 1.0%), BP recording is 76.7% (England 83.4%), BMI is 72.3% (-2.7 pp; England 82.1%), and alcohol is 72.7% (-5.2 pp; England 81.8%). Moderate effort to run.
Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.
Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.
Option 3
Learning disability register validation
Learning disability prevalence is 0.5% (206 patients, 5.8% of the Liverpool register) versus 0.6% across Liverpool, the ICB and England, an unadjusted gap of +57 to +60 patients. For discussion: practices could validate register coding against existing clinical records and review annual health check invitation templates for accessibility. Low cost, quick to run.
Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.
Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.
Provenance and audit trail
Provenance and audit trail
Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.
| Recommendation | Indicator(s) | Policy anchor | Data level |
|---|---|---|---|
| Learning disability register audit (p2) | Learning disability: QOF prevalence | 75% annual health checks (Network Contract DES) · Oliver McGowan | PCN |
| Physical health check recall (p4) | SMI register with a BP check in the last 12 months | MHIS · From Harm to Hope | PCN |
| Hypertension case finding audit (p5) | Hypertension register | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Preschool immunisation recall outreach (p6) | MMR dose 2 coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| Cervical screening recall outreach (p7) | Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs) | Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026 | PCN |
| Option 1 · Hypertension case-finding and register audit (p12) | Hypertension register · Hypertension: QOF prevalence · Aged 65+ | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Option 2 · SMI physical health check recall (p12) | Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BP check in the last 12 months | MHIS · From Harm to Hope | PCN |
| Option 3 · Learning disability register validation (p12) | Learning disability register · Learning disability: QOF prevalence | 75% annual health checks (Network Contract DES) · Oliver McGowan | PCN |
Data sources
Data sources
Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.
| Dataset | Level | Period | Used for |
|---|---|---|---|
| Coplug indicator tables: census, deprivation and QOF measures | PCN & Practice | 2023 to 2025, projected to 2030; 2023 to 2024 | Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 |
| MHCLG, Rough sleeping snapshot in England: autumn 2025 | Local authority | Autumn 2025 | Pages 2, 4 |
| OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) | PCN | 2024/25 | Pages 2, 4 |
| OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002) | Local authority | 2024/25; 2022-24 | Pages 2, 4 |
| ONS, Census 2021 TS039: provision of unpaid care (age-standardised) | Local authority | Census 2021 | Pages 2, 4 |
| QOF registers, prevalence and care processes (Coplug indicator tables) | Practice | 2023 to 2025, projected to 2030 | Pages 4, 5, 6, 7, 8, 10 |
| UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26 | PCN & Practice | Q1 2025/26 | Pages 4, 6 |
| UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026 | Local authority | 2025/26 season to 28 Feb 2026 | Pages 4, 6 |
| NHS England, Cancer Waiting Times: July 2026 monthly time series with revisions | ICB & Provider | Jul 2026 (provisional) | Pages 7, 8 |
| NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental data | ICB & Local authority | Jun 2026 (provisional) | Pages 7, 8 |
| NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026 | Provider | Jul 2026 | Pages 7, 8 |
| National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022 | ICB | 2022 | Pages 7, 8 |
| NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted) | Practice | Survey Jan-Apr 2026 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domain | Practice | 2025/26 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domain | Practice | 2025/26 | Page 9 |
| Coplug indicator catalogue — definitions, cohorts, policy anchors | Reference | Current | Evidence-base lines, page 13 |
Methods, data-quality notes and limitations
Methods, data-quality notes and limitations
Methods
Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.
Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.
Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.
Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.
